Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Jan 2025 for Black Diamond Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Erika Jones: trading record in brief
All filings by Erika Jones on record concern Black Diamond Therapeutics, Inc. Between 15 February 2022 and 30 January 2025, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 31 January 2025 came the latest disclosure, a share grant in Black Diamond Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erika Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
75,000 shares0Common StockSEC:0001415889-25-002489:0
5,075 shares0Common StockSEC:0001104659-23-022388:0
5,075 shares0Common StockSEC:0001415889-22-001515:0
3 of 3 declarations
